Articles On Global Health (ASX:GLH)

Melodiol Global Health have announced a non-binding Letter of Intent (LOI) to divest two of its business units – Sierra Sage Herbs (SSH) and Halucenex Life Sciences (Halucenex) – to US-based Panacea Life Sciences (OTCQB:PLSH) for an initial...

The ASX 200 put on a much better show today, with a +0.46% gain at closing time Sectors wise, Materials turned yesterday’s frown upside down Notable performers today: Pilbara Minerals; DXN; Si6 Metals; Strickland Metals   It’s been a much...

The ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks carried the torch with enthusiasm, while Materials wasn’t let anywhere near said torch Notable performers today: pharma stock Telix (ASX:TLX...

Melodiol Global Health’s wholly-owned Australian Subsidiary Health House (HHI) has demonstrated it’s heading in the right direction for the half ended 30 June 2023. Melodiol Global Health (ASX:ME1) closed the acquisition of HHI, an interna...

Lawyers for descendants of the late Peter Wright were first on the stand today, taking on Gina Rinehart over ownership and royalties relating to Hope Downs iron ore operations in the Pilbara. It’s day one of the Supreme Court of Western...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

What a time to be alive. As the clock struck midnight to herald the start of the 23/24 financial year, Australia’s ability to legally prescribe through qualified medical practitioners MDMA (ecstasy) and psilocybin – the active ingredient in...

After a strong start, the ASX levelled out as the market digested news there will be a new RBA Governor. The RBA will be led by a female for the first time, with deputy governor Michele Bullock replacing Phillip Lowe from September. ...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

The ASX 200 finishes up 1.56%  The ASX XEC rises 1.52% All 11 sectors were higher lead by Real Estate   The ASX 200 managed a decent 1.56% lift today, and the ASX XEC was also in the green, up 1.52%.  All of 11 sectors were higher, led b...

Melodial’s targeted M&A strategy is starting to pay off as its subsidiaries Heart Health International and Mernova boost revenue across the group to deliver a record quarter. Melodiol Global Health (ASX:ME1) has reported a material acc...

As demand grows for its range of recreational cannabis products, ME1 has recorded strong sales figures in the June quarter via a 42% increase on pcp in Q2 FY23. This also led Mernova to achieve a 20% revenue rise in H1 FY23 when compared to...

Health House Australia and UK operating units have become the second and third Melodiol Global Health subsidiaries to achieve a cash flow or adjusted EBITDA positive result. Melodiol Global Health Limited (ASX:ME1) has announced recent fin...

An already buoyant ASX boosted past +1.1% on happy CPI data for May. Consumer Discretionary just pipped by Real Estate, both up more than 2.1%. Stellar Resources takes line honours after hitting fresh zinc finds in Tassie.   A pleasing ba...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

ASX waddled to a -0.3% close, like a toddler with a turd in its trousers. Even the goldies retreated, with the XGD ASX All Ords Gold index dropping 0.20%. Blackmores sale is the most exciting thing to happen all day… which says it all, rea...

Telehealth specialist Global Health signs partnership deal with Woolworths subsidiary The deal will see Global Health provide virtual access to healthcare practitioners Orthocell hires experts to drive US market entry   Telehealth special...

Saturday March 11 was a typical balmy autumnal afternoon in Melbourne, but Neuren (ASX:NEU) chief Jon Pilcher was despondent as he awaited news from the company’s US partner Acadia on whether the US Food and Drug Administration (FDA) had ap...

The ASX 200 was up 0.39% and ASX XEC slips 0.42% 10 out of 11 sectors were higher lead by Communications The Real Estate sector was the only one in the red   The ASX 200 was up 0.39% today and the ASX XEC was down 0.42%.  A total of 10 ou...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Market goes out too hard, too early and beds down for a lengthy afternoon snooze Tempus Resources still riding high after drilling into phenomenally good gold grades Betting is now open on how long until the ASX’s next “how to announce stu...

The George Institute for Global Health has announced an agreement with the global investment firm, Hillhouse, for the purchase of George Clinical.

ASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11 sectors finish lower China could reopen next year with ‘seismic’ implications for the rest of the world   The local bourse has dropped for...

ASX 200 down 0.55% on lower than normal volume  Small cap index falls 0.96% and 10 out 11 sectors finish lower Economy grows for the fourth consecutive quarter, up 0.6%    The ASX200 was down 0.55% today, and the ASX Emerging Companies...

ShareCafeSlowing Economic Growth and Three Sectors Set to Benefit What a year 2022 has been. From skyrocketing inflation and heightened geo-political tensions to global talent shortages and an energy crisis. But as the year draws to a close...

ASX 200 down -0.4% Small cap index loses -1.7%  Way2VAT: killing it in the VAT space The small caps index has been smashed on Monday as the local Energy and Resources Sectors took fright from what is easily the scariest social unrest acro...

The University of New South Wales announced 8 winners in the inaugural UNSW Founders Awards this week, recognising founders, startups and mentors for their outstanding contribution to innovation and the startup ecosystem. Virtual job simula...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX200 weakens in arvo trade ASX small caps index sheds 0.3% Victory Goldfields is really, really winning REE   Just ahead of the close on Thursday, the S&P/ASX 200 was doing its best to shake off a decent session, despite most sector...

The University of NSW – the place where Atlassian’s Scott Farquhar and Mike Cannon-Brookes met – has announced its finalists for the inaugural UNSW Founders Awards. The awards, announced later this month at a gala dinner in Sydney on Novemb...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Creso Pharma (CPH) is looking to change its name to Melodiol Global Health to reflect its growth strategyAlso as part of this strategy, Creso welcomes two new directors to its board following the resignation of Non-Executive Director and Fo...

ASX cannabis shares have leapt back onto investor radars and are likely to grab more media headlines in the weeks ahead. While all three are deep in the red today amid wider selling action that sees the All Ordinaries Index (ASX: XAO) down...

A potential takeover of Ramsay Healthcare’s (RHC) 50:50 subsidiary, Ramsay Sime Darby Health Care, will not go aheadIHH Healthcare Berhad had made a conditional, non-binding indicative proposal to acquire the business in March, however, IHH...

In times of great uncertainty the Australian healthcare sector can offer investors plenty of choice, with varying degrees of risk and opportunities. -Australia’s healthcare sector has seen record government investment-Global pandemic has ac...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Global Health (GLH) secures a contract with the Yarram District Health Service to provide various solutions to the hospital and community health services in Yarram, Victoria This contract win is the first for FY22/23 and it is also the fir...

Ansell announces net zero commitment by 2040 Emyria extends its library of novel MDMA-like compounds  to >125 Genetic Technologies partners with Melbourne based Siles Health Protective personal equipment Ansell (ASX:ANN) has just annou...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Merewether C...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Highlights Global Health has inked two key contracts with Homeless Healthcare and Peninsula Health. The contracts build on the healthcare firm’s momentum and existing relationships in Western Australia and Victoria. The contracts have...

ShareCafeAustralia’s Impact on the U.S. Infant Milk Powder Crisis The share prices in both Bubs Australia (ASX: BUB) and a2 Milk (ASX: A2M) have been soaring on the back of news that they can provide aid to the current supply shortage in th...

Global Health (GLH) secures three new contracts with Arcadia Healthcare, Matilda Nepean Private Hospital, and Waikiki Private Hospital to implement a range of its solutions The contracts represent a total value of $185,400 in annual recurr...

Actor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Franchise Global Health has established the first legal seedbank in Denmark Botanix nabs FDA Qualified Infection Disease Product designation for...